American Rebel Holdings heads into next week's May 14 earnings with a stock in freefall and a borrow market under extreme strain.
Short sellers have moved aggressively into this micro-cap over the past two weeks. Short interest as a percentage of the free float has exploded from roughly 0.8% in mid-April to 31.3% by May 7 — a gain of nearly 384% week-on-week — making it one of the fastest-building short positions in the small-cap universe right now. The ORTEX short score is running at 81.5, near the top of its recent range and in the 99th percentile of the broader market, reflecting just how extreme the positioning has become in a very short time.
The borrow market tells an equally urgent story. Availability has collapsed to effectively zero — no shares remain in the lending pool relative to what is already borrowed, the tightest reading ORTEX has recorded for this name all year. Cost to borrow has climbed to 265% annualised, up 19% on the week, meaning it costs a short seller more than two-and-a-half times the stock's value per year just to maintain the position. The combination of near-zero availability and triple-digit borrow costs signals a lending market under acute pressure. Yet despite those costs, short interest kept building — a sign that conviction on the downside is strong enough to absorb the pain.
The price action has been brutal. AREB closed at $0.17 on May 8, down 46% on the week and down 97% over the past month. The market cap has shrunk to roughly $592,000, placing this firmly in the micro-cap distressed category where normal valuation frameworks do not apply. Institutional ownership data shows just three reported holders with minimal positions, underscoring how thin and illiquid the shareholder base has become. Two fresh 424B2 prospectus filings with the SEC on May 8 point to ongoing equity issuance activity, which in a stock already down 97% over a month is a significant dilution signal.
History here offers a sobering parallel. At the April 9 earnings release, the stock fell 83% in a single day. A second event on March 31 produced the same 83% one-day loss. The next confirmed earnings date is May 14 — five days away. The prior two prints each produced near-total single-session collapses, and that pattern sets the context for the current positioning, even without projecting what happens next.
Peer-correlated names are holding up far better. MIMI on Nasdaq is up 7.4% on the day, and ACVA gained more than 21% on the week. The contrast suggests the distress in AREB is idiosyncratic rather than sector-driven, making the short build even more pointed. What to watch into May 14: whether the prospectus filings result in fresh share issuance before the earnings date, and whether borrow costs spike further as availability remains pinned at zero.
See the live data behind this article on ORTEX.
Open AREB on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
